Cargando…
Case Report: Administration of Amniotic Fluid-Derived Nanoparticles in Three Severely Ill COVID-19 Patients
Rationale/Objectives: A human coronavirus (HCoV-19) has caused the novel coronavirus disease (COVID-19) outbreak worldwide. There is an urgent need to develop new interventions to suppress the excessive immune response, protect alveolar function, and repair lung and systemic organ damage. Zofin (pre...
Autores principales: | Mitrani, Maria Ines, Bellio, Michael A., Sagel, Anthony, Saylor, Marie, Kapp, William, VanOsdol, Kathryn, Haskell, Gwendolyn, Stewart, Danique, Abdullah, Zanub, Santos, Ivan, Milberg, Julian, Arango, Alissa, Mitrani, Albert, Shapiro, George C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010176/ https://www.ncbi.nlm.nih.gov/pubmed/33816515 http://dx.doi.org/10.3389/fmed.2021.583842 |
Ejemplares similares
-
Treatment of a COVID-19 long hauler with an amniotic fluid-derived extracellular vesicle biologic
por: Mitrani, Maria Ines, et al.
Publicado: (2021) -
Administration of amniotic fluid derived extracellular vesicle is associated with decreased crp in COVID-19 patients
por: Mitrani, M., et al.
Publicado: (2021) -
Human amniotic fluid derived extracellular vesicles attenuate T cell immune response
por: del Rivero, Tania, et al.
Publicado: (2022) -
Proof-of-concept trial of an amniotic fluid-derived extracellular vesicle biologic for treating high risk patients with mild-to-moderate acute COVID-19 infection
por: Bellio, Michael A., et al.
Publicado: (2021) -
Control of Early Flame Kernel Growth by Multi-Wavelength Laser Pulses for Enhanced Ignition
por: Dumitrache, Ciprian, et al.
Publicado: (2017)